Onco-proteogenomics: cancer proteomics joins forces with genomics

Area of Science:

• Oncology
• Proteomics
• Genomics

Background:

• Tumor genome complexity is increasingly understood, yet proteome regulation remains unclear.
• Standard proteomics relies on known protein databases, missing cancer-specific transcriptome variations like mutations, splice variants, and gene fusions.

Purpose of the Study:

• To introduce and explain the concept of onco-proteogenomics.
• To highlight the limitations of current proteomics in capturing cancer-specific proteomic profiles.
• To propose an integrated approach for a comprehensive understanding of cancer biology.

Main Methods:

• Onco-proteogenomics integrates mass spectrometry data with genomic information.
• This approach identifies tumor-specific peptides by analyzing cancer transcriptomes.
• It links measurements from tumor-derived DNA, RNA, and proteins.

Main Results:

• Standard proteomics workflows fail to capture unique cancer peptides arising from mutations and alternative splicing.
• Onco-proteogenomics enables the identification of these tumor-specific peptides.
• The integration of multi-omics data provides a more complete picture of the cancer proteome.

Conclusions:

• Onco-proteogenomics offers a powerful strategy to bridge the gap between cancer genomics and proteomics.
• Linking DNA, RNA, and protein data is crucial for a deeper understanding of cancer biology.
• This integrated approach has the potential to uncover novel cancer mechanisms and therapeutic targets.